Drug Trial Radar · NCT07220083
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
286
Planned (sponsor's estimate)
Start
Feb 16, 2026
Primary completion
Dec 27, 2028
Study completion Jan 24, 2029
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Oct 23, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
PODOMOUNT-pFSGS This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 helps people with FSGS. Participants are put into 2 groups randomly, which means by chance. Every participant has an equal chance of being in each group. One group takes BI 764198 tablets, and the other group takes placebo tablets. Placebo tablets look like BI 764198 tablets but do not contain any medicine. Participants take a tablet once a day for up to 2 years. All participants also continue their standard medication for FSGS. Participants are in the study for up to 2 years. During this time, they visit the study site about every 3 months. Participants regularly collect urine samples. This is done to check their kidneys. The results are compared between the two groups to see whether the treatment works. The doctors also regularly check participants' health and take note of any unwanted effects.
Conditions
- Focal Segmental Glomerulosclerosis
Interventions
BI 764198Drug
BI 764198
PlaceboDrug
Placebo matching BI 764198
Primary outcomes
What the sponsor says the trial is designed to measure.
- Relative change in 24-hour UPCR (measured in mg/g) from baseline to Week 104Time frame: Baseline and Week 104
Locations
309 sites in 37 countries. Site status is shown where the registry gives one.
Alabama Kidney Research
Alabaster, Alabama · Recruiting
Apogee Clinical Research
Huntsville, Alabama · Recruiting
Southwest Kidney Institute
Surprise, Arizona · Recruiting
West Coast Kidney Institute
Fremont, California · Recruiting
Kidney Disease Medical Group
Glendale, California · Recruiting
Amicis Research Center - Balboa
Granada Hills, California · Recruiting
Valiance Clinical Research
Huntington Park, California · Recruiting
Academic Medical Research Institute - Glendale
Los Angeles, California · Recruiting
Kaiser Permanente - Los Angeles Medical Center
Los Angeles, California · Recruiting
University of California Los Angeles
Los Angeles, California · Not yet recruiting
Valley Renal Medical Group - Northridge
Northridge, California · Not yet recruiting
Shasta Critical Care Specialists
Redding, California · Recruiting
North America Research Institute
San Dimas, California · Recruiting
Kaiser Permanente - French Campus
San Francisco, California · Recruiting
Valiance Clinical Research-Tarzana-68237
Tarzana, California · Recruiting
National Institute of Clinical Research - Victorville
Victorville, California · Recruiting
Kidney Associates of Colorado - Denver
Denver, Colorado · Recruiting
Colorado Kidney Care
Denver, Colorado · Recruiting
Florida Kidney Physicians - Boca Raton
Boca Raton, Florida · Recruiting
Florida Kidney Physicians, LLC - Fort Lauderdale
Fort Lauderdale, Florida · Recruiting
Total Research Group, LLC
Miami, Florida · Recruiting
CTR Oakwater, LLC
Orlando, Florida · Recruiting
Coastal Nephrology and Associates
Port Charlotte, Florida · Recruiting
Florida Kidney Physicians - Riverview/Brandon
Riverview, Florida · Recruiting
Emory Children's Center
Atlanta, Georgia · Not yet recruiting
Coastal Medical Research, LLC
Brunswick, Georgia · Recruiting
Southeast Kidney Associates - East Point
East Point, Georgia · Recruiting
Memorial Health University Hospital
Savannah, Georgia · Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois · Not yet recruiting
Northwestern University
Chicago, Illinois · Not yet recruiting
Endeavor Health
Evanston, Illinois · Recruiting
Kidney Care Center - Olympia Fields
Olympia Fields, Illinois · Recruiting
Nephrology Physicians - Mishawaka
Mishawaka, Indiana · Recruiting
EmVenio Research Inc. - Kansas City
Kansas City, Kansas · Recruiting
Wichita Nephrology Group
Wichita, Kansas · Recruiting
Renal Associates of Baton Rouge
Baton Rouge, Louisiana · Recruiting
Northwest Louisiana Nephrology
Shreveport, Louisiana · Recruiting
Johns Hopkins Hospital
Baltimore, Maryland · Recruiting
Joslin Diabetes Center
Boston, Massachusetts · Not yet recruiting
Henry Ford Hospital
Detroit, Michigan · Recruiting
Showing 40 of 309 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.